Pay in 4 interest-free payments of $5.88 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
For use by qualified research professionals only
Rachmin, I., Ostrowski, S
A 2025 review in The Journal of Bone and Joint Surgery further emphasized that patients with obesity can still achieve meaningful functional improvement, but require preoperative medical optimization, weight management, consideration of bariatric surgery and GLP-1 receptor agonists, and multidisciplinary perioperative planning (Koh et al., 2025)
The result is a peptide with a half-life of 159 to 195 hours, roughly 7 to 8 days, making once-weekly administration possible
To view a copy of this licence, visit About this article Cite this article Lee, SY., Roh, H., Gonzalez-Perez, D
US$ 20.33
US$ 27.67
US$ 29.64
US$ 24.19
